Concentration-dependent dual effect of thrombin on impaired growth/apoptosis or mitogenesis in tumor cells
Open Access
- 15 May 2000
- journal article
- Published by American Society of Hematology in Blood
- Vol. 95 (10), 3133-3138
- https://doi.org/10.1182/blood.v95.10.3133
Abstract
Because thrombin-treated tumor cell-induced metastasis increases tumor nodule volume12 greater than nodule number, we studied the effect of thrombin on tumor cell growth in vitro and in vivo (murine B16F10 melanoma, human HCT8 colon carcinoma, DU145 prostate carcinoma). Tumor cell growth was measured after 3 to 7 days in 1% fetal calf serum (FCS) + RPMI 1640. We found that, whereas relatively low concentrations of thrombin, 0.1 to 0.5 U/mL (1-5 nmol/L) enhance tumor cell growth in vitro approximately 2- to 3-fold, higher concentrations, 0.5 to 1 U/mL (5-10 nmol/L) impaired cell growth approximately 2- to 4-fold. Impaired cell growth was associated with cell cycle arrest at G2M and increased pre-GoDNA, as well as apoptosis, measured by tumor cell binding to Annexin V and propidium iodide. Apoptosis was reversed with the general caspase inhibitor, FK-011. The enhancing and inhibiting effects were specific for thrombin (reversed with inactive diisopropyl-fluorophosphate [DFP]-thrombin) and mediated via the protease-activated receptor 1 (PAR-1). PAR-1 activation was demonstrated by (1) use of a cell line, B16F10, devoid of the 3 other thrombin receptors, PAR-3, PAR-4, and GPIb; and (2) greater sensitivity of PAR-1 transfected B16F10 and HCT8 cells to impaired cell growth/apoptosis, 3- and 14-fold, respectively. Thus, thrombin has a bimodal effect on PAR-1 in tumor cells: enhanced growth at low concentration, impaired growth/apoptosis at higher concentration.Keywords
This publication has 32 references indexed in Scilit:
- Thrombin Inhibits Tumor Cell Growth in Association with Up-regulation of p21 and Caspases via a p53-independent, STAT-1-dependent PathwayPublished by Elsevier BV ,2000
- Caspase-3 Activation Is Not Responsible for Vinblastine-induced Bcl-2 Phosphorylation and G2/M Arrest in Human Small Cell Lung Carcinoma Ms-1 CellsJapanese Journal of Cancer Research, 1998
- Irradiation induces G2/M cell cycle arrest and apoptosis in p53-deficient lymphoblastic leukemia cells without affecting Bcl-2 and Bax expressionCell Death & Differentiation, 1998
- Thrombin Receptor Activating Mutations: ALTERATION OF AN EXTRACELLULAR AGONIST RECOGNITION DOMAIN CAUSES CONSTITUTIVE SIGNALINGPublished by Elsevier BV ,1996
- Presence of the seven transmembrane thrombin receptor on human tumour cells: effect of activation on tumour adhesion to platelets and tumour tyrosine phosphorylationBritish Journal of Haematology, 1996
- Thrombin stimulates melanoma tumor‐cell binding to endothelial cells and subendothelial matrixInternational Journal of Cancer, 1993
- Highly purified human α-thrombin promotes morphological transformation of BALB/c 3T3 cellsCarcinogenesis: Integrative Cancer Research, 1992
- Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activationCell, 1991
- Role of the Coagulation System in Tumor-Cell-Induced Platelet Aggregation and MetastasisPathophysiology of Haemostasis and Thrombosis, 1988
- Conditions which affect initiation of animal cell division by trypsin and thrombinJournal of Cellular Physiology, 1978